Clinical Trial Update: LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

View source ↗

Summary

Clinical trial update indicates a long-term safety study of Siliq (brodalumab) versus other therapies for adults with moderate-to-severe psoriasis is ongoing an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• SILIQ (brodalumab)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Status: ENROLLING_BY_INVITATION